Nucleos(t)ide analog therapy of chronic hepatitis b and liver cancer risk reduction: better nucleotides than nucleosides?
Source: Gastroenterology - Category: Gastroenterology Authors: Pietro Lampertico, Massimo Colombo Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Hepatitis | Hepatitis B | Liver | Urology & Nephrology